About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker KROS

Latest patent grants
GrantedPatentOwnerTypeSource
Oct 20, 202612766147
Methods of treating cardiovascular-related disease
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Oct 6, 202612753149
N-formylhydroxylamines as neprilysin (NEP) inhibitors, in particular…
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Mar 24, 202612582700
Activin receptor type IIA variants and methods of use thereof
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Jan 13, 202612522646
Activin receptor type II chimeras and methods of use thereof
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Dec 30, 202512508262
Methods of using ALK2 inhibitors
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Dec 2, 202512485104
Amino acid derivatives containing a disulfanyl group as an inhibitor…
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Nov 4, 202512458693
Methods of treating iron overload with a BMP inhibitor
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Oct 14, 202512440539
Methods of using activin receptor type IIB variants
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Sep 2, 202512404313
GDNF fusion polypeptides and methods of use thereof
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Aug 19, 202512391710
Method for the industrial preparation of the disodium salt of ((2S)-3…
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Jul 22, 202512364737
Activin receptor type IIA variants and methods of use thereof
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Jul 8, 202512350313
Activin receptor type IIa variants and methods of use thereof
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Jun 17, 202512331124
ALK2 antibodies and methods of use thereof
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗
Apr 8, 202512269858
Activin receptor type IIB variants and methods of use thereof
KROS
Keros Therapeutics, Inc.
utilityGoogle Patents ↗

14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:13 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances